Juliet Livadiotis
Non-Executive Director
Juliet is an Investment Advisor at Northern Gritstone.
Immediately prior to working with Northern Gritstone, Juliet has been involved in CMS Ventures, with a focus on Seed/Series A Stage biotechnology, particularly pre-clinical stage therapeutics companies. Juliet has worked for Oxford Biotherapeutics Ltd as UK Director of Corporate Development and also was co-founder of Cambridge Gene Therapy, a spinout company established to further commercial development of the CAM-GM2 therapy.
Immediately prior to working with Northern Gritstone, Juliet has been involved in CMS Ventures, with a focus on Seed/Series A Stage biotechnology, particularly pre-clinical stage therapeutics companies. Juliet has worked for Oxford Biotherapeutics Ltd as UK Director of Corporate Development and also was co-founder of Cambridge Gene Therapy, a spinout company established to further commercial development of the CAM-GM2 therapy.
